506
Views
0
CrossRef citations to date
0
Altmetric
Clinical Research

Insulin-euglycemia therapy in acute aluminum phosphide poisoning: a randomized clinical trial

ORCID Icon, , , &
Pages 1032-1039 | Received 25 Mar 2023, Accepted 31 Oct 2023, Published online: 14 Dec 2023

References

  • Moghadamnia AA. An update on toxicology of aluminum phosphide. Daru. 2012;20(1):25.
  • Boedeker W, Watts M, Clausing P, et al. The global distribution of acute unintentional pesticide poisoning: estimations based on a systematic review. BMC Public Health. 2020;20(1):1875. doi: 10.1186/s12889-020-09939-0.
  • Gunnell D, Eddleston M. Suicide by intentional ingestion of pesticides: a continuing tragedy in developing countries. Int J Epidemiol. 2003;32(6):902–909. doi: 10.1093/ije/dyg307.
  • Karunarathne A, Bhalla A, Sethi A, et al. Importance of pesticides for lethal poisoning in India during 1999 to 2018: a systematic review. BMC Public Health. 2021;21(1):1441. doi: 10.1186/s12889-021-11156-2.
  • Singh S, Singh D, Wig N, et al. Aluminum phosphide ingestion–a clinico-pathologic study. J Toxicol Clin Toxicol. 1996;34(6):703–706. doi: 10.3109/15563659609013832.
  • Holger JS, Engebretsen KM, Fritzlar SJ, et al. Insulin versus vasopressin and epinephrine to treat beta-blocker toxicity. Clin Toxicol. 2007;45(4):396–401. doi: 10.1080/15563650701285412.
  • Rotella JA, Greene SL, Koutsogiannis Z, et al. Treatment for beta-blocker poisoning: a systematic review. Clin Toxicol. 2020;58(10):943–983. doi: 10.1080/15563650.2020.1752918.
  • St-Onge M, Dubé PA, Gosselin S, et al. Treatment for calcium channel blocker poisoning: a systematic review. Clin Toxicol. 2014;52(9):926–944. doi: 10.3109/15563650.2014.965827.
  • Hassanian-Moghaddam H. Probable benefit of hyperinsulinemia-euglycemia and hyperventilation oxygenation on aluminium phosphide poisoning. Clin Toxicol. 2008;46(7):592.
  • Hassanian-Moghaddam H, Zamani N. Therapeutic role of hyperinsulinemia/euglycemia in aluminum phosphide poisoning. Medicine. 2016;95(31):e4349. doi: 10.1097/MD.0000000000004349.
  • Pannu AK, Bhalla A, Gantala J, et al. Glucose-insulin-potassium infusion for the treatment of acute aluminum phosphide poisoning: an open-label pilot study. Clin Toxicol. 2020;58(10):1004–1009. doi: 10.1080/15563650.2020.1719131.
  • Woodward C, Pourmand A, Mazer-Amirshahi M. High dose insulin therapy, an evidence based approach to beta blocker/calcium channel blocker toxicity. Daru. 2014;22(1):36.
  • Doig GS, Simpson F, Delaney A. A review of the true methodological quality of nutritional support trials conducted in the critically ill: time for improvement. Anesth Analg. 2005;100(2):527–533. doi: 10.1213/01.ANE.0000141676.12552.D0.
  • Alnasser S, Hussain SM, Kirdi TS, et al. Aluminum phosphide poisoning in Saudi Arabia over a nine-year period. Ann Saudi Med. 2018;38(4):277–283. doi: 10.5144/0256-4947.2018.277.
  • Agrawal VK, Bansal A, Singh RK, et al. Aluminum phosphide poisoning: possible role of supportive measures in the absence of specific antidote. Indian J Crit Care Med. 2015;19(2):109–112. doi: 10.4103/0972-5229.151019.
  • Shabana A, Dholoo F, Banerjee P. Inotropic agents and vasopressors in the treatment of cardiogenic shock. Curr Heart Fail Rep. 2020;17(6):438–448. doi: 10.1007/s11897-020-00493-9.
  • Mehrpour O, Jafarzadeh M, Abdollahi M. A systematic review of aluminium phosphide poisoning. Arh Hig Rada Toksikol. 2012;63(1):61–73. doi: 10.2478/10004-1254-63-2012-2182.
  • Karami-Moh S, Jafari A, Abdollahi M. Comprehensive review of the mechanistic approach and related therapies to cardiovascular effects of aluminum phosphide. Int J Pharmacol. 2013;9(8):493–500. doi: 10.3923/ijp.2013.493.500.
  • Jang DH, Spyres MB, Fox L, et al. Toxin-induced cardiovascular failure. Emerg Med Clin North Am. 2014;32(1):79–102. doi: 10.1016/j.emc.2013.10.003.
  • Kerns W. 2nd. Management of beta-adrenergic blocker and calcium channel antagonist toxicity. Emerg Med Clin North Am. 2007;25(2):309–331; abstract viii. doi: 10.1016/j.emc.2007.02.001.
  • Randin D, Vollenweider P, Tappy L, et al. Effects of adrenergic and cholinergic blockade on insulin-induced stimulation of calf blood flow in humans. Am J Physiol. 1994;266(3 Pt 2):R809–816. doi: 10.1152/ajpregu.1994.266.3.R809.
  • Vollenweider L, Tappy L, Owlya R, et al. Insulin-induced sympathetic activation and vasodilation in skeletal muscle. Effects of insulin resistance in lean subjects. Diabetes. 1995;44(6):641–645.
  • Olver TD, Laughlin MH, Padilla J. Exercise and vascular insulin sensitivity in the skeletal muscle and brain. Exerc Sport Sci Rev. 2019;47(2):66–74. doi: 10.1249/JES.0000000000000182.
  • Padilla J, Olver TD, Thyfault JP, et al. Role of habitual physical activity in modulating vascular actions of insulin. Exp Physiol. 2015;100(7):759–771. doi: 10.1113/EP085107.
  • Limberg JK, Smith JA, Soares RN, et al. Sympathetically mediated increases in cardiac output, not restraint of peripheral vasodilation, contribute to blood pressure maintenance during hyperinsulinemia. Am J Physiol Heart Circ Physiol. 2020;319(1):H162–h170. doi: 10.1152/ajpheart.00250.2020.
  • ELabdeen S, Saad K, Oreby M, et al. Assessment of intravenous lipid emulsion as an adjuvant therapy in acute aluminum phosphide poisoning: a randomized controlled trial. Ain Shams J Forensic Med Clin Toxicol. 2020;34(1):51–68. doi: 10.21608/ajfm.2020.68225.
  • Abd Elghany S, Heshmat M, Oreby M, et al. Evaluation of various scoring systems in prediction of acute aluminum phosphide (ALP) poisoning outcome. Ain Shams J Forensic Med Clin Toxicol. 2018;30(1):117–127. doi: 10.21608/ajfm.2018.18202.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.